Entangled Vision

About us

Age-related macular degeneration (AMD) is the leading cause of blindness in people over 60 and accounts for 90% of new cases of blindness in Canada. Early diagnosis is critical to preserve a patient’s vision, unfortunately, studies show that up to 25% of people over 60 show early signs of AMD that their eye doctor has not detected.

At Entangled Vision, we use technology from the world of quantum information to detect AMD before vision loss begins. Our test costs patients only $15, can detect AMD earlier than the standard-of-care, and can be upgraded to test for other disorders through software updates alone. Clinics stand to capture $25 billion in revenue by treating currently undiagnosed AMD patients and can treat more patients in a day by automating AMD screening.

Program engagement

Entangled Vision

Leadership

Connor Kapahi

Founder and CEO

Status

Intellectual Property

Fundraising

Sector

Subsector